丹参酮ⅡA 磺酸钠注射液对原发性高血压患者血脂水平及内皮功能的影响 |
| |
引用本文: | 朱雪莲 鲁利民 朱锦萍 金辉 孟静. 丹参酮ⅡA 磺酸钠注射液对原发性高血压患者血脂水平及内皮功能的影响[J]. 现代生物医学进展, 2016, 16(20): 3932-3935 |
| |
作者姓名: | 朱雪莲 鲁利民 朱锦萍 金辉 孟静 |
| |
作者单位: | 中国中医科学院西苑医院社区保健科; 北京大学第三医院药剂科;北京积水潭医院药剂科;北京市老年医院药剂科北 |
| |
基金项目: | 北京市自然科学基金项目(7072032) |
| |
摘 要: | 目的:研究丹参酮ⅡA磺酸钠注射液对原发性高血压患者血脂水平及内皮功能的影响。方法:选择2013年5月-2015年10月在我院首次诊断为原发性高血压的80例患者作为研究对象,根据治疗方法不同将入组患者随机分为实验组和对照组。实验组患者接受丹参酮ⅡA磺酸钠注射液联合口服降压药物治疗,对照组患者仅接受口服降压药物治疗,比较两者患者治疗前后的血压、肝肾功能、血脂水平以及内皮功能指标的变化。结果:治疗后,两组患者的收缩压、舒张压水平均低于治疗前,且实验组患者的收缩压、舒张压水平与对照组比较均无统计学差异。治疗后,两组患者的ALT、AST、Scr水平均与治疗前比较均无显著差异,且实验组患者的ALT、AST、Scr水平与对照组比较无统计学差异。治疗后,实验组患者的TC、TG、LDL水平明显低于治疗前(P0.05),对照组患者的TC、TG、LDL与治疗前比较无统计学差异(P0.05),实验组患者的TC、TG、LDL水平显著低于对照组(P0.05)。结论:丹参酮ⅡA磺酸钠注射液有助于改善原发性高血压患者的血脂代谢以及内皮功能,且对患者的肝肾功能无明显影响。
|
关 键 词: | 原发性高血压;丹参酮ⅡA;血脂;内皮功能 |
Effect of SodiumTanshinone IIA Sulfonate Injection on the Blood LipidLevel and Endothelial Function of Patients with Primary Hypertension |
| |
Abstract: | Objective:To study the effect of sodium tanshinone IIA sulfonate injection on blood lipid level and endothelialfunction of patients with primary hypertension.Methods:80 patients first diagnosed as primary hypertension in our hospital from May2013 to October 2015 were collected as the research object and randomly divided into the experimental group and control groupaccording to different treatment methods. The patients in experimental group received tanshinone IIA sulfonate injection combined withoral antihypertensive drug therapy, patients in the control group only received oral antihypertensive drug therapy. Then the changes ofblood pressure levels, liver and kidney function, blood lipid levels and endothelial function of two groups before and after treatment werecompared.Results:After the treatment, the systolic blood pressure, diastolic blood pressure levels of both groups were lower than thosebefore treatment and the systolic blood pressure, diastolic blood pressure levels of experimental group had no significant differencecompared with the control group (P>0.05); after treatment, the ALT, AST, SCR contents of both groups had no significant differencecompared with those before treatment and the ALT, AST, SCR contents of experimental group had no statistical difference comparedwith the control group (P>0.05); after treatment, the TC, TG, LDL levels of experimental group were significantly lower than those ofcontrol group (P<0.05).Conclusion:Tanshinone II A sodiuminjection was helpful to improve the blood lipid metabolismand endothelialfunction of patients with primary hypertension and had positive clinical application value. |
| |
Keywords: | Hypertension Tanshinone A Blood lipid Endothelial function |
本文献已被 CNKI 等数据库收录! |
| 点击此处可从《现代生物医学进展》浏览原始摘要信息 |
|
点击此处可从《现代生物医学进展》下载全文 |
|